Functional magnetic resonance imaging (fMRI) studies in APOE-ε4 carriers have shown differential patterns of brain activations during various memory tasks in the regions affected by AD, relative to noncarriers [9]–[13]. This evidence concerns the gene APOE and Alzheimer disease.